OBJECTIVES: Although cell culture techniques and animal models of intimal hyperplasia have increased our current understanding of the aetiology of vein graft stenosis, the results of such studies have been difficult to relate to the human situation. DESIGN: The present study was designed to validate an organ culture of human saphenous vein by comparing the changes occurring in cultured vein with those seen in pathological vein graft stenoses and to identify a suitable marker of cell proliferation. MATERIALS AND METHODS: Saphenous vein segments were cultured for 14 days, fixed in formalin and processed for immunohistochemistry. Freshly excised stenoses were fixed and processed similarly. A number of markers of cell proliferation were evaluated in the culture system in order to identify the one best suited to this particular model. RESULTS: Marked similarities were observed in the cellular and extracellular matrix composition, and electron microscopy revealed that both the neointima of the cultured vein and the pathological lesion contained an abundance of smooth muscle cells of a secretory phenotype. Bromodeoxyuridine proved to be the most reliable proliferation marker and revealed that early proliferation in the superficial layers of the vein intima gave rise to the formation of neointima. Both proliferation and neointimal thickness were maximal by day 14 in culture. Proliferation declined rapidly thereafter, and the neointima was maintained. CONCLUSIONS: The changes occurring in cultured vein and graft stenoses bore many similarities, thereby justifying the use of organ culture as a valuable experimental tool.
OBJECTIVES: Although cell culture techniques and animal models of intimal hyperplasia have increased our current understanding of the aetiology of vein graft stenosis, the results of such studies have been difficult to relate to the human situation. DESIGN: The present study was designed to validate an organ culture of human saphenous vein by comparing the changes occurring in cultured vein with those seen in pathological vein graft stenoses and to identify a suitable marker of cell proliferation. MATERIALS AND METHODS: Saphenous vein segments were cultured for 14 days, fixed in formalin and processed for immunohistochemistry. Freshly excised stenoses were fixed and processed similarly. A number of markers of cell proliferation were evaluated in the culture system in order to identify the one best suited to this particular model. RESULTS: Marked similarities were observed in the cellular and extracellular matrix composition, and electron microscopy revealed that both the neointima of the cultured vein and the pathological lesion contained an abundance of smooth muscle cells of a secretory phenotype. Bromodeoxyuridine proved to be the most reliable proliferation marker and revealed that early proliferation in the superficial layers of the vein intima gave rise to the formation of neointima. Both proliferation and neointimal thickness were maximal by day 14 in culture. Proliferation declined rapidly thereafter, and the neointima was maintained. CONCLUSIONS: The changes occurring in cultured vein and graft stenoses bore many similarities, thereby justifying the use of organ culture as a valuable experimental tool.
Authors: Luciana B Lopes; Colleen M Brophy; Charles R Flynn; Zhengping Yi; Benjamin P Bowen; Christopher Smoke; Brandon Seal; Alyssa Panitch; Padmini Komalavilas Journal: J Vasc Surg Date: 2010-09-22 Impact factor: 4.268
Authors: Sun Hyung Kwon; Li Li; Yuxia He; Chieh Sheng Tey; Huan Li; Ilya Zhuplatov; Seung-Jung Kim; Christi M Terry; Donald K Blumenthal; Yan-Ting Shiu; Alfred K Cheung Journal: J Vasc Res Date: 2016-01-21 Impact factor: 1.934
Authors: B Kumar; K Dreja; S S Shah; A Cheong; S-Z Xu; P Sukumar; J Naylor; A Forte; M Cipollaro; D McHugh; P A Kingston; A M Heagerty; C M Munsch; A Bergdahl; A Hultgårdh-Nilsson; M F Gomez; K E Porter; P Hellstrand; D J Beech Journal: Circ Res Date: 2006-01-26 Impact factor: 17.367
Authors: Krishna Madhavan; Winston H Elliott; Walter Bonani; Eric Monnet; Wei Tan Journal: J Biomed Mater Res B Appl Biomater Date: 2012-11-19 Impact factor: 3.368
Authors: Daniel J Wong; Daniel Y Lu; Clinton D Protack; Go Kuwahara; Hualong Bai; Nirvana Sadaghianloo; George Tellides; Alan Dardik Journal: J Vasc Surg Date: 2014-10-24 Impact factor: 4.268
Authors: R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter Journal: Diabetologia Date: 2010-05-12 Impact factor: 10.122
Authors: Yujun Cai; Walter E Knight; Shujie Guo; Jian-Dong Li; Peter A Knight; Chen Yan Journal: J Pharmacol Exp Ther Date: 2012-08-22 Impact factor: 4.030
Authors: Michael J Osgood; Kyle M Hocking; Igor V Voskresensky; Fan Dong Li; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy Journal: J Vasc Surg Date: 2013-07-30 Impact factor: 4.268
Authors: Thomas S Monahan; Nicholas D Andersen; Michelle C Martin; Junaid Y Malek; Gautam V Shrikhande; Leena Pradhan; Christiane Ferran; Frank W LoGerfo Journal: FASEB J Date: 2008-10-21 Impact factor: 5.191